

On Demand webinar: FeNO Plan on a Page
Are you struggling to persuade your Integrated Care Board (ICB) to fund FeNO testing? With the new BTS/NICE/SIGN asthma guideline recommending FeNO for asthma diagnostic testing, this can create quite a challenging for primary care providers. There can also be uncertainty around when to use it and when not to and many will not be alone in this uncertainty.
In this webinar, Katherine Hickman (PCRS executive chair) and guest speaker Sanjeev Rana (GP) discussed:
- What FeNO is and why it's so important in diagnosing asthma,
- Addressing common barriers,
- How to align recommendations with national guidance, and
- How to help you build confidence in implementing FeNO testing across primary care.
You may also be interested in...
In this article published in Primary Care Respiratory Update (Oct 2015) Carol Stonham describes the use of FENO testing for diagnosing and monitoring asthma. There is also a slide set presented by Carol Stonham on FeNo at the PCRS Respiratory Conference 2018 to complement the article.
The fractional exhaled nitric oxide (FeNO) test measures the level of NO in the exhaled breath and provides an indication of eosinophilic inflammation in the lungs.
In this article produced for Practice Nurse, author, PCRS Chair, Carol Stonham, describes FeNO testing and its role in diagnosing respiratory disease. She discusses the advantages and limitations of this test.